Lauren Lucas is currently pursuing a Ph.D. in Pharmaceutical Sciences at the Harrison School of Pharmacy at Auburn University, focusing on the pharmacology option. She has been awarded the Presidential Graduate Research Fellowship from Auburn University and previously earned a B.S. in Biochemistry from The Georgia Institute of Technology. She is advised by Dr. David Riese. The Riese lab studies the Epidermal Growth Factor (EGF) family of peptide hormones and their receptors, the ErbB receptor tyrosine kinases. This network regulates the proliferation and differentiation of epithelial cells and deregulated signaling by this network contributes to human tumorigenesis and increased tumor cell invasiveness, metastatic potential, and chemoresistance. Consequently, we seek to understand the mechanism by which this network regulates cell function, with the ultimate goal being the development of novel cancer treatments. Lauren’s specific research focus is on the development of approaches to identify and characterize ERBB4 candidate tumor driver mutants in melanoma.
Tuesday, October 27, 2020
4:15 PM – 4:30 PM ET